UK Markets close in 2 hrs 41 mins

BioNTech SE (22UA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
306.00-2.30 (-0.75%)
As of 02:29PM CET. Market open.
Full screen
Previous close308.30
Bid0.00 x N/A
Ask0.00 x N/A
Day's range301.20 - 314.00
52-week range65.40 - 396.90
Avg. volume15,916
Market cap74.141B
Beta (5Y monthly)N/A
PE ratio (TTM)65.76
EPS (TTM)4.65
Earnings date09 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Editor's pick
    Yahoo Finance Video

    'We’re being overly cautious and overly vigilant': Doctor on Omicron

    Dr. Manish Garg, Emergency Medicine Physician & Co-Founder of World Academic Council of Emergency Medicine, joins Yahoo Finance to discus the spread of the Omicron COVID-19 variant. 

  • Editor's pick
    Yahoo Finance Video

    ‘We can’t have countries lingering at 10%' COVID-19 vaccination, Columbia professor explains

    Columbia University professor Meg Fitzgerald speaks with Yahoo Finance Live about the uncertainty surrounding Omicron, the effectiveness (or lack thereof) of travel bans, the demand for booster shots, global vaccination rates, and the strained U.S. health care system. 

  • Motley Fool

    Why Novavax and Pfizer Are Trouncing the Market Today

    On yet more worrying news about the omicron variant of the coronavirus, the fortunes of coronavirus stocks were mixed on Tuesday. In contrast the co-developer of Pfizer's jab, BioNTech (NASDAQ: BNTX), was down by almost 3%. It's interesting that the fortunes of partners Pfizer and BioNTech, which together developed the Comirnaty vaccine, were diverging so sharply.